Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology
A Multi-center, Prospective, Self-Controlled Diagnostic Accuracy Comparative Studies of Artificial Intelligence Diagnostic System for Surgical Neuropathology
研究概览
地位
条件
详细说明
In this study, 141 patients will be recruited. After being enrolled, the patients will accept surgery and specimens for pathological analysis will be taken according to the routine treatment process.
The histopathologic slides will then be digitized by a whole-slide scanner. The images will be reviewed by gold standard committee for evaluation of ground truth. And then be separately diagnosed by Artificial Intelligence Diagnostic System and practicing pathologists. So the investigators can compare the diagnostic efficiency of Artificial Intelligence with that of pathologists, thus understand the gap between artificial intelligence and actual clinical practice.
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients or their guardians understand the research process, agree to use their data, and sign the informed consent form;
- Aged >=18 years;
- MRI shows intracranial spaceoccupying lesions;
- The clinical diagnosis is glioma, metastasis or lymphoma thus requiring surgical treatment;
- The patient is willing to accept the surgery.
Exclusion Criteria:
- The patient has serious underlying diseases thus is not suitable for surgery;
- After further clinical evaluation, surgical treatment was not the best choice;
- The patient participate in clinical research of other drugs or devices;
- The researchers believe that there are other factors that will make the patients unable to complete the study.
学习计划
研究是如何设计的?
设计细节
- 主要用途:诊断
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Artificial Intelligence
A deep learning based artificial intelligence diagnostic system(DOI:10.1093/neuonc/noaa163)
|
The investigators will use the Artificial Intelligence Diagnostic System to review the H&E stained slide of each patient and then report the classification of the tumor on a 10-type scale.
|
|
有源比较器:Practicing Pathologists
One pathologist who has at least 5 years of experience
|
The ordinary pathologist will review the H&E stained slide of each patient(without additional informations such as: Immunohistochemistry et al.) and then report the classification of the tumor on a 10-type scale only bases on the slide images
|
|
其他:Gold Standard
A committee composed of two expert pathologists who has at least 10 years of experience and one expert pathologist who has at least 15 years of experience
|
Firstly, the two expert pathologist(>=10 years of experience) will review the H&E stained slide of each patient on their own (with additional informations such as: Immunohistochemistry et al.) and then report the classification of the tumor on a 10-type scale.If they report the same opinion, that opinion will perform as the ground truth; while if their opinion clash with each other, the expert pathologist(>=15 years of experience) will get involved and the agreement of three experts will perform as the ground truth
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diagnostic Accuracy of Study Arms
大体时间:1 week after the last patient's diagnosis is completed
|
The number of correctly diagnosed participants by study arms divided by the total number of participants
|
1 week after the last patient's diagnosis is completed
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Sensitivity and specificity of Study Arms
大体时间:1 week after the last patient's diagnosis is completed
|
Sensitivity and specificity of study arms for each type calculated by 2x2 tables
|
1 week after the last patient's diagnosis is completed
|
|
Spearman Coefficient of Study Arms related to Gold Standard
大体时间:1 week after the last patient's diagnosis is completed
|
Spearman Correlation Analysis between Study Arms and Gold Standard
|
1 week after the last patient's diagnosis is completed
|
合作者和调查者
赞助
调查人员
- 研究主任:Cuiyun Wu, Ph.D、Huashan Hospital
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- PAAI2020
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.